UPDATE: UBS Assumes Royalty Pharma (RPRX) at Buy
Tweet Send to a Friend
(Updated - June 13, 2022 4:54 PM EDT)
UBS analyst Ashwani Verma assumes coverage on Royalty Pharma (NASDAQ: RPRX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
UBS analyst Ashwani Verma assumes coverage on Royalty Pharma (NASDAQ: RPRX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
